Investors

Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

Investor Contacts

Financial PR and Investor Relations

Paul McManus, Helen Cresswell and Lianne Cawthorne Walbrook PR Ltd 4 Lombard Street London EC3V 9HD

Tel: +44 (0)20 7933 8780

Email: shield@walbrookpr.com